Test Price
2,800 AED✅ Home Collection Available
ACTA1 Gene Nemaline Myopathy Type 3 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين ACTA1 للاعتلال العضلي الخيطي من النوع الثالث بتقنية التسلسل الجيني المتقدم في الإمارات | 2800 درهم إماراتي | وفق إرشادات هيئة الصحة بدبي لعام 2026
Executive Summary | ملخص تنفيذي
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via Next Generation Sequencing (NGS) with ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy — 8 AM to 11 PM, 7 days a week across all Emirates.
Clinical Guidance: Telephonic Post-Test Clinical Guidance with a qualified genetic counsellor to support result interpretation and next steps.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731 — instant confirmation within minutes.
يقدم هذا التحليل الجيني المتقدم فحصاً شاملاً لجين ACTA1 المرتبط بالاعتلال العضلي الخيطي من النوع الثالث، وذلك وفق أعلى معايير الجودة المعتمدة من هيئة الصحة بدبي ودولة الإمارات العربية المتحدة، مع ضمان الدقة التشخيصية والخصوصية الكاملة للبيانات.
Clinical Overview
The ACTA1 Gene Nemaline Myopathy Type 3 Genetic Test is a definitive molecular diagnostic assay that screens the entire coding region of the ACTA1 gene using Next Generation Sequencing technology to identify pathogenic variants associated with autosomal dominant and autosomal recessive nemaline myopathy type 3 — a congenital neuromuscular disorder characterized by muscle weakness, hypotonia, and the presence of nemaline rods on muscle biopsy. يكتشف هذا التحليل الطفرات الجينية المسؤولة عن الاعتلال العضلي الخيطي لتمكين التشخيص الدقيق والتخطيط العلاجي المبكر.
| Feature | Our Test — DHA-Certified | Closest Alternative |
|---|---|---|
| Precision | 99.9% Diagnostic Sensitivity — Full ACTA1 Gene Coverage via NGS | Variable; May Miss Deep Intronic or Regulatory Variants |
| Method | Next Generation Sequencing (NGS) with Clinical-Grade Bioinformatics Pipeline & MLV Confirmation | Sanger Sequencing Only or Targeted Hotspot Panel |
| Speed (TAT) | 3 to 4 Weeks with Expedited Reporting Option Available | 6 to 8 Weeks Standard Turnaround |
| Pre-Test Support | Included Genetic Counselling Session with Pedigree Charting | Often Not Included or Limited to Basic Consent |
Physician Insight & Safety Protocol
Dr. PRABHAKAR REDDY
DHA License: 61713011 | Clinical Pathologist & Genetic Testing Specialist
"A genetic diagnosis is a deeply personal and emotional journey — I want every patient and family to know that this test result is a tool for clarity, not a standalone verdict. Clinical correlation with a neurologist and genetic counsellor is essential to fully interpret pathogenic ACTA1 variants in the context of your unique clinical presentation and family history. Please remember that knowledge empowers, and with the right medical team beside you, every finding becomes an actionable step toward better care and informed family planning."
— Dr. Prabhakar Reddy, DHA 61713011
⚠️ Medication Warning: Do not discontinue prescribed medication without consulting your doctor. Genetic test results may inform long-term management strategies but must never be used to abruptly alter or stop any current prescribed therapy without direct physician supervision.
🛡️ Safety Exclusion Criteria & Emergency Red Flags
Exclusion Criteria — Do NOT Proceed If:
- Patient is currently hemodynamically unstable or hospitalized in ICU without treating physician clearance.
- Acute febrile illness or active systemic infection within 48 hours — may affect sample integrity.
- Inability to provide informed consent (patient or legal guardian for minors per UAE CDS Law 2026).
- Recent blood transfusion (within 4 weeks) — may introduce donor DNA confounding.
🚨 Emergency Red Flags — Seek Immediate Medical Attention:
- Acute respiratory distress or newly onset dysphagia in a patient with suspected nemaline myopathy.
- Sudden loss of ambulation or significant worsening of muscle weakness within 24–48 hours.
- Signs of malignant hyperthermia susceptibility — urgent anaesthesiology consultation required.
- Cardiac arrhythmia or cardiomyopathy symptoms in confirmed ACTA1-related myopathy.
If you or the patient experience any of the above, please proceed to the nearest emergency department immediately. This genetic test is an elective diagnostic procedure and does not replace emergency medical care.
UAE Regulatory Compliance & Data Privacy
Federal Decree-Law No. 41 of 2024 (Art. 87): This laboratory strictly adheres to all provisions governing genetic testing, including mandatory pre-test genetic counselling, informed consent protocols, and prohibition of genetic discrimination in insurance and employment.
CDS Law 2026 — Minors Protection: Genetic testing for minors requires documented consent from a legal guardian and a court-approved medical necessity determination. All minor samples are processed under enhanced ethical oversight.
UAE PDPL — Personal Data Protection Law: All genetic data is classified as sensitive personal data under UAE PDPL. Data is encrypted at rest and in transit (AES-256), stored on UAE-sovereign servers, and never shared with third parties without explicit written consent.
ISO 9001:2015 Certification: Certificate INT/EGQ/2509DA/3139 — audited and renewed annually. Our quality management system covers sample collection, processing, bioinformatics analysis, and clinical reporting.
Patient FAQ & Clinical Guidance
Q1: What does the ACTA1 gene test diagnose, and who should consider it?
This test identifies pathogenic mutations in the ACTA1 gene responsible for nemaline myopathy type 3, a congenital neuromuscular disorder, and should be considered by individuals with unexplained muscle weakness, hypotonia, or a family history of congenital myopathies seeking definitive molecular diagnosis. يُوصى بهذا الاختبار للأفراد الذين يعانون من ضعف عضلي غير مفسر أو تاريخ عائلي للاعتلالات العضلية الخلقية.
Q2: Is a genetic counselling session mandatory before the blood draw?
Yes, a pre-test genetic counselling session is mandatory under UAE Federal Decree-Law No. 41 of 2024 to draw a comprehensive pedigree chart, discuss potential outcomes, and ensure fully informed consent before any sample is collected for this ACTA1 analysis. نعم، جلسة الاستشارة الوراثية إلزامية بموجب القانون الاتحادي الإماراتي قبل سحب العينة لضمان الموافقة المستنيرة الكاملة.
Q3: How long until I receive my results, and how will they be delivered?
Results are delivered within 3 to 4 weeks via a secure, encrypted online portal with an accompanying telephonic clinical guidance session from a qualified genetic counsellor who will walk you through every clinically significant finding in plain language. تُسلم النتائج خلال ثلاثة إلى أربعة أسابيع عبر بوابة إلكترونية آمنة مع جلسة إرشاد سريري هاتفية شاملة.
Primary Referring Specialists
This test also serves Sports Scientists, Anti-Aging Specialists, Legal Professionals, and individuals seeking peace of mind through definitive genetic clarity.
Pre-Test Requirements
- Clinical History: A detailed clinical history of the patient undergoing the ACTA1 Gene Nemaline Myopathy Type 3 Genetic must be provided to the ordering physician.
- Genetic Counselling: A mandatory genetic counselling session to draw a pedigree chart of family members affected with ACTA1 gene-related nemaline myopathy type 3 must be completed prior to sample collection.
- Sample Type: Peripheral venous blood collected in EDTA tubes via ISO-certified cold-chain phlebotomy.
- Medication Disclosure: Full disclosure of all current medications, supplements, and recent blood transfusions to the phlebotomist at the time of collection.
License: 9834453 | ISO 9001:2015 Cert: INT/EGQ/2509DA/3139 | DHA-Compliant Laboratory
📞 +971 54 548 8731 | 📱 WhatsApp
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians